Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase I Safety and Tolerability Study of the Oncolux System for Intratumoral Delivery of Non-Coherent Light for the Photoactivation of LS 11 in Patients With Refractory Solid Tumors

NCT00028405 is registered in ClinicalTrials.gov with Light Sciences LLC as lead sponsor.

NCT NCT00028405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00028405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase I Safety and Tolerability Study of the Oncolux System for Intratumoral Delivery of Non-Coherent Light for the Photoactivation of LS 11 in Patients With Refractory Solid Tumors
Lead sponsor
Light Sciences LLC
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2001
Completion date
December 31, 2002
Enrollment
48
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, head and neck cancer, liver metastasis, mouth cancer, pelvic cancer, rectal cancer, sarcoma